Havenga MJ - Search Results

1

Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector.

van Leeuwen EB, Cloosen S, Senden-Gijsbers BL, Agervig Tarp M, Mandel U, Clausen H, Havenga MJ, Duffour MT, García-Vallejo JJ, Germeraad WT, Bos GM. van Leeuwen EB, et al. Among authors: havenga mj. Cytotherapy. 2006;8(1):24-35. doi: 10.1080/14653240500513018. Cytotherapy. 2006. PMID: 16627342

2

Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.

Slager EH, van der Minne CE, Goudsmit J, van Oers JM, Kostense S, Havenga MJ, Osanto S, Griffioen M. Slager EH, et al. Among authors: havenga mj. Cancer Gene Ther. 2004 Mar;11(3):227-36. doi: 10.1038/sj.cgt.7700674. Cancer Gene Ther. 2004. PMID: 14726960

3

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Havenga MJ, Lemckert AA, Ophorst OJ, van Meijer M, Germeraad WT, Grimbergen J, van Den Doel MA, Vogels R, van Deutekom J, Janson AA, de Bruijn JD, Uytdehaag F, Quax PH, Logtenberg T, Mehtali M, Bout A. Havenga MJ, et al. J Virol. 2002 May;76(9):4612-20. doi: 10.1128/jvi.76.9.4612-4620.2002. J Virol. 2002. PMID: 11932426 Free PMC article.

4

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.

Ophorst OJ, Kostense S, Goudsmit J, De Swart RL, Verhaagh S, Zakhartchouk A, Van Meijer M, Sprangers M, Van Amerongen G, Yüksel S, Osterhaus AD, Havenga MJ. Ophorst OJ, et al. Among authors: havenga mj. Vaccine. 2004 Aug 13;22(23-24):3035-44. doi: 10.1016/j.vaccine.2004.02.011. Vaccine. 2004. PMID: 15297053

5

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

Rea D, Havenga MJ, van Den Assem M, Sutmuller RP, Lemckert A, Hoeben RC, Bout A, Melief CJ, Offringa R. Rea D, et al. Among authors: havenga mj. J Immunol. 2001 Apr 15;166(8):5236-44. doi: 10.4049/jimmunol.166.8.5236. J Immunol. 2001. PMID: 11290808

6

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.

Brouwer E, Havenga MJ, Ophorst O, de Leeuw B, Gijsbers L, Gillissen G, Hoeben RC, ter Horst M, Nanda D, Dirven C, Avezaat CJ, Goudsmit J, Sillevis Smitt P. Brouwer E, et al. Among authors: havenga mj. Cancer Gene Ther. 2007 Feb;14(2):211-9. doi: 10.1038/sj.cgt.7701010. Epub 2006 Nov 3. Cancer Gene Ther. 2007. PMID: 17082793

7

Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.

Kuhlmann KF, van Geer MA, Bakker CT, Dekker JE, Havenga MJ, Elferink RP, Gouma DJ, Bosma PJ, Wesseling JG. Kuhlmann KF, et al. Among authors: havenga mj. Cancer Gene Ther. 2009 Jul;16(7):585-97. doi: 10.1038/cgt.2009.4. Epub 2009 Jan 30. Cancer Gene Ther. 2009. PMID: 19180144

8

Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells.

de Gruijl TD, Ophorst OJ, Goudsmit J, Verhaagh S, Lougheed SM, Radosevic K, Havenga MJ, Scheper RJ. de Gruijl TD, et al. Among authors: havenga mj. J Immunol. 2006 Aug 15;177(4):2208-15. doi: 10.4049/jimmunol.177.4.2208. J Immunol. 2006. PMID: 16887980

9

Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber.

Goossens PH, Havenga MJ, Pieterman E, Lemckert AA, Breedveld FC, Bout A, Huizinga TW. Goossens PH, et al. Among authors: havenga mj. Arthritis Rheum. 2001 Mar;44(3):570-7. doi: 10.1002/1529-0131(200103)44:3<570::AID-ANR105>3.0.CO;2-Y. Arthritis Rheum. 2001. PMID: 11263771 Free article.

10

Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B.

Knaän-Shanzer S, Van Der Velde I, Havenga MJ, Lemckert AA, De Vries AA, Valerio D. Knaän-Shanzer S, et al. Among authors: havenga mj. Hum Gene Ther. 2001 Nov 1;12(16):1989-2005. doi: 10.1089/104303401753204562. Hum Gene Ther. 2001. PMID: 11686940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page